These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 16491292
1. Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKL. Middleton-Hardie C, Zhu Q, Cundy H, Lin JM, Callon K, Tong PC, Xu J, Grey A, Cornish J, Naot D. J Bone Miner Res; 2006 Mar; 21(3):438-45. PubMed ID: 16491292 [Abstract] [Full Text] [Related]
2. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK. Théoleyre S, Kwan Tat S, Vusio P, Blanchard F, Gallagher J, Ricard-Blum S, Fortun Y, Padrines M, Rédini F, Heymann D. Biochem Biophys Res Commun; 2006 Aug 25; 347(2):460-7. PubMed ID: 16828054 [Abstract] [Full Text] [Related]
3. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H. Biochem Biophys Res Commun; 2000 Sep 07; 275(3):768-75. PubMed ID: 10973797 [Abstract] [Full Text] [Related]
4. Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone. Salmon P. J Bone Miner Res; 2004 May 07; 19(5):695-702. PubMed ID: 15068491 [Abstract] [Full Text] [Related]
5. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells. Koh JM, Lee YS, Byun CH, Chang EJ, Kim H, Kim YH, Kim HH, Kim GS. J Endocrinol; 2005 Jun 07; 185(3):401-13. PubMed ID: 15930166 [Abstract] [Full Text] [Related]
6. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation. Sun SG, Lau YS, Itonaga I, Sabokbar A, Athanasou NA. J Pathol; 2006 May 07; 209(1):114-20. PubMed ID: 16482498 [Abstract] [Full Text] [Related]
8. Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor. Yamada N, Tsujimura T, Ueda H, Hayashi S, Ohyama H, Okamura H, Terada N. Cytokine; 2005 Aug 21; 31(4):288-97. PubMed ID: 15996478 [Abstract] [Full Text] [Related]
9. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K. Mandelin J, Li TF, Hukkanen M, Liljeström M, Salo J, Santavirta S, Konttinen YT. J Rheumatol; 2005 Apr 21; 32(4):713-20. PubMed ID: 15801030 [Abstract] [Full Text] [Related]
10. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. Cao JJ, Singleton PA, Majumdar S, Boudignon B, Burghardt A, Kurimoto P, Wronski TJ, Bourguignon LY, Halloran BP. J Bone Miner Res; 2005 Jan 21; 20(1):30-40. PubMed ID: 15619667 [Abstract] [Full Text] [Related]
11. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA. J Bone Miner Res; 2001 Jun 21; 16(6):1004-14. PubMed ID: 11393777 [Abstract] [Full Text] [Related]
12. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity. Lossdörfer S, Schwartz Z, Wang L, Lohmann CH, Turner JD, Wieland M, Cochran DL, Boyan BD. J Biomed Mater Res A; 2004 Sep 01; 70(3):361-9. PubMed ID: 15293309 [Abstract] [Full Text] [Related]
13. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT. J Bone Miner Res; 2001 Oct 01; 16(10):1787-94. PubMed ID: 11585342 [Abstract] [Full Text] [Related]
14. Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland. Hofbauer LC, Kluger S, Kühne CA, Dunstan CR, Burchert A, Schoppet M, Zielke A, Heufelder AE. J Cell Biochem; 2002 Oct 01; 86(4):642-50. PubMed ID: 12210731 [Abstract] [Full Text] [Related]
15. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. Lu HK, Chen YL, Chang HC, Li CL, Kuo MY. J Periodontal Res; 2006 Aug 01; 41(4):354-60. PubMed ID: 16827732 [Abstract] [Full Text] [Related]
16. Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis. Nyambo R, Cross N, Lippitt J, Holen I, Bryden G, Hamdy FC, Eaton CL. J Bone Miner Res; 2004 Oct 01; 19(10):1712-21. PubMed ID: 15355567 [Abstract] [Full Text] [Related]